ViennaLab Publications

Full list of all ViennaLab publications

ViennaLab Diagnostics offers a variety of easy-to-use in vitro diagnostic kits for the detection of genetic mutations, as well as genetic predispositions, pharmacogenetics and oncology.

Their genetics test are split in two different technologies. They offer the quick and cost efficiënt RealFast assays which are based on hydrolysis probes. ViennaLab also offers StripAssays which can cover more mutations in one assay due to reverse hybridisation.

 

TitleAuthorDate Product
the natural history of alpha-1 antitrypsin deficiency, and associated liver disease
S. Townsend2018Alpha-1 antitrypsin
Risk of Lung Disease in PI MZ HeterozygotesEdwin K. Silverman2016Alpha-1 antitrypsin
Multicenter Validation Study of a Novel StripAssay for Cystic FibrosisHelene Pühringer2018Cystic Fibrosis
Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPDJames K. Stoller2016Alpha-1 antitrypsin
Genetic Testing for Familial Mediterranean Fever in Austria by Means of Reverse-Hybridization TeststripsChristian Oberkanins2003FMF
Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common a-thalassemia point mutations and deletionsHelene Pühringer2007Thalassemia
Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesterone Stefan Németh 2012
Lactase Non-Persistence Genotyping: Comparison of Two Real-Time PCR Assays and Assessment of Concomitant Fructose/Sorbitol Malabsorption Rates Dietmar Enko 2016LCT-13910
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced MyopathyLB Ramsey2014pharmacogenetics
Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimensVeronika Buxhofer-Ausch2013KRAS/BRAF

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm
Noel G. McElvaney2015Alpha-1 antitrypsin
Genetic Modifiers in b-Thalassemia Intermedia: A Study on 102 Iraqi Arab PatientsNasir A.S. Al-Allawi2015Thalassemia
Beta-thalassemia: from genotype to phenotypeFabrice Danjou2011Thalassemia
Variants in genetic modifiers of b-thalassemia can help to predict the major or intermedia type of the diseaseCatherine Badens2011Thalassemia
A genetic score for the prediction of beta-thalassemia severity Fabrice Danjou2015Thalassemia
Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis Qin Wu2015hepatitis C
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceC. Castellani2008Cystic Fibrosis
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionStéphanie Bibert2013IL28B
IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvirand RibavirinEric G. Meissner2014
Sensitive Detection of KRAS Mutations in Archived Formalin-Fixed Paraffin-Embedded Tissue Using Mutant-Enriched PCR and Reverse-HybridizationChristoph Ausch2009KRAS
Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients Josephine H. Li 2014 SLCO1B1*5
Comprehensive analysis of CYP2D6 variants and copy numbers using reverse-hybridization and real-time PCR based assaysAnne Berndt2017CYP2D6